Manish Bhaiyya

Dr. Manish Bhaiyya


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2026 in Microchimica Acta
Verified
Journal Article
Open access
PAPurshottam J. Assudani
Purshottam J. Assudani
BPBalakrishnan P
Balakrishnan P
AAAnny Leema A
Anny Leema A
GGGina George
Gina George
AAAnkita Avthankar
Ankita Avthankar
Madhusudan KulkarniMadhusudan Kulkarni
Madhusudan Kulkarni
Foodborne pathogens such as Escherichia coli (E. Coli), Salmonella, and Listeria monocytogenes continue to pose a major potential threat to global public health and therefore rapid, accurate, and field-deployable detection methods are still extremely desirable. This review describes cutting-edge examples of advanced biosensing platforms for the strategy of detecting these priority pathogens, focusing on clinical detection and highlighting electrochemical, optical, and microfluidic sensing modalities. This has been enabled by recent advances in functional nanomaterials, molecular recognition elements (including aptamers and nanozymes), and surface engineering strategies rendering sensors much ‘smarter’/improved in terms of sensitivity, specificity, and behaviour towards complex food matrices. However blending these biosensors with artificial intelligence (AI) and Machine Learning (ML) enabled intelligent pattern recognition, real-time analytics, and multiplexing at high-speed, turning traditional detection systems into smart diagnostic devices. We critically review recent case studies in light of biosensor design, signal transduction mechanisms, models of AI, performance validation, and applicability in different food environments. The principal challenges are identified which include matrix interference, instability of biorecognition elements, limitations in scalability, and the need for regulatory standardization. We discuss these with associated mitigation strategies that are technically sound, including ratiometric sensing, microfluidic pre-treatment techniques, explainable AI, and printable electronics. Forward-looking, we discuss biosensors enabled by being self-powered, biosensor hubs with modular pathogen panels, blockchain incorporation, and standardized validation pipelines. This review offers a prospective view toward enabling intelligent, robust, and regulation-ready biosensing platforms for next-generation food safety monitoring through the bridging of technological innovations with practical implementation.

27 January 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
CSChirag Mukesh Singhal
Chirag Mukesh Singhal
VKVani Kaushik
Vani Kaushik
AAAbhijeet Rajendra Awasthi
Abhijeet Rajendra Awasthi
JZJitendra B. Zalke
Jitendra B. Zalke
SPSangeeta Palekar
Sangeeta Palekar
Manish BhaiyyaManish Bhaiyya
Manish Bhaiyya
A novel, portable chemiluminescence (CL) sensing platform powered by deep learning and smartphone integration has been developed for cost-effective and selective glucose detection. This platform features low-cost, wax-printed micro-pads (WPµ-pads) on paper-based substrates used to construct a miniaturized CL sensor. A 3D-printed black box serves as a compact WPµ-pad sensing chamber, replacing traditional bulky equipment, such as charge coupled device (CCD) cameras and optical sensors. Smartphone integration enables a seamless and user-friendly diagnostic experience, making this platform highly suitable for point-of-care (PoC) applications. Deep learning models significantly enhance the platform’s performance, offering superior accuracy and efficiency in CL image analysis. A dataset of 600 experimental CL images was utilized, out of which 80% were used for model training, with 20% of the images reserved for testing. Comparative analysis was conducted using multiple deep learning models, including Random Forest, the Support Vector Machine (SVM), InceptionV3, VGG16, and ResNet-50, to identify the optimal architecture for accurate glucose detection. The CL sensor demonstrates a linear detection range of 10–1000 µM, with a low detection limit of 8.68 µM. Extensive evaluations confirmed its stability, repeatability, and reliability under real-world conditions. This deep learning-powered platform not only improves the accuracy of analyte detection, but also democratizes access to advanced diagnostics through cost-effective and portable technology. This work paves the way for next-generation biosensing, offering transformative potential in healthcare and other domains requiring rapid and reliable analyte detection.

28 May 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
AKAmol Shashikantrao Kulkarni
Amol Shashikantrao Kulkarni
SKSarika Khandelwal
Sarika Khandelwal
YTYogesh Thakare
Yogesh Thakare
JRJyoti Rangole
Jyoti Rangole
Madhusudan KulkarniMadhusudan Kulkarni
Madhusudan Kulkarni
Manish BhaiyyaManish Bhaiyya
Manish Bhaiyya
Integrating three-dimensional printing (3DP) in healthcare has modernized medical diagnostics and therapies by presenting various accurate, efficient, and patient-specific tailored solutions. This review critically examines the integration of 3DP in the development of miniaturized devices specifically tailored for point-of-care testing (PoCT) applications in healthcare. Focusing on progressive additive manufacturing techniques, such as material extrusion, vat photopolymerization, and powder bed fusion, the review classifies and evaluates their contributions toward designing compact, portable, and patient-specific diagnostic devices. Unlike previous reviews that treat 3DP or PoCT generically, this work uniquely bridges the technical innovations of 3DP with clinical applications by analyzing wearable sensors, biosensors, lab-on-chip systems, and microfluidic platforms. It highlights recent case studies, performance metrics, and the role of 3DP in enhancing diagnostic speed, accessibility, and personalization. The review also explores challenges such as material standardization and regulatory hurdles while outlining future directions involving artificial intelligence (AI), the Internet of Things (IoT), and multifunctional integration. This focused assessment establishes 3DP as a transformative force in decentralized and precision healthcare.

14 October 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
SBSampa Manoranjan Barman
Sampa Manoranjan Barman
APArpita Parakh
Arpita Parakh
AAAnny Leema A
Anny Leema A
BPBalakrisnan P
Balakrisnan P
AAAnkita Avthankar
Ankita Avthankar
Manish BhaiyyaManish Bhaiyya
Manish Bhaiyya
Single-molecule detection (SMD) has reformed analytical science by enabling the direct observation of individual molecular events, thus overcoming the limitations of ensemble-averaged measurements. This review presents a comprehensive analysis of the principles, devices, and emerging materials that have shaped the current landscape of SMD. We explore a wide range of sensing mechanisms, including surface plasmon resonance, mechanochemical transduction, transistor-based sensing, optical microfiber platforms, fluorescence-based techniques, Raman scattering, and recognition tunneling, which offer distinct advantages in terms of label-free operation, ultrasensitivity, and real-time responsiveness. Each technique is critically examined through representative case studies, revealing how innovations in device architecture and signal amplification strategies have collectively pushed the detection limits into the femtomolar to attomolar range. Beyond the sensing principles, this review highlights the transformative role of advanced nanomaterials such as graphene, carbon nanotubes, quantum dots, MnO2 nanosheets, upconversion nanocrystals, and magnetic nanoparticles. These materials enable new transduction pathways and augment the signal strength, specificity, and integration into compact and wearable biosensing platforms. We also detail the multifaceted applications of SMD across biomedical diagnostics, environmental monitoring, food safety, neuroscience, materials science, and quantum technologies, underscoring its relevance to global health, safety, and sustainability. Despite significant progress, the field faces several critical challenges, including signal reproducibility, biocompatibility, fabrication scalability, and data interpretation complexity. To address these barriers, we propose future research directions involving multimodal transduction, AI-assisted signal analytics, surface passivation techniques, and modular system design for field-deployable diagnostics. By providing a cross-disciplinary synthesis of device physics, materials science, and real-world applications, this review offers a comprehensive roadmap for the next generation of SMD technologies, poised to impact both fundamental research and translational healthcare.

3 October 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AKAmol S. Kulkarni
Amol S. Kulkarni
SKSarika Khandelwal
Sarika Khandelwal
KMKavita Manekar
Kavita Manekar
PAPurshottam J. Assudani
Purshottam J. Assudani
RGRangnath Girhe
Rangnath Girhe
Manish BhaiyyaManish Bhaiyya
Manish Bhaiyya
Fast and reliable monitoring of metabolic biomarkers, including glucose and lactate, is critical for chronic diseases, sepsis, and other scenarios involving physiological stress. However, most diagnostic options depend on multiple serial tests, require complicated testing apparatus, and are too expensive to be useful in the point-of-care arena. To address these limitations, we present a portable, low-cost, and 3D-printed (3DP) electrochemiluminescence (ECL) biosensor capable of simultaneously detecting glucose and lactate in a single step. The biosensor incorporates interdigitated electrodes (IDEs) within a bipolar electrode (BPE) electrochemical system to enhance electron transfer and signal amplification. Through careful optimization of voltage, luminol concentration, and pH, strong and reproducible ECL signals were achieved, with detection limits of 0.1 mM for glucose (linear range 0.1 mM to 5.0 mM) and 80 µM for lactate (linear range 0.1 mM to 4.0 mM). Real serum analysis yielded 95–102% recovery rates, validating the device’s clinical relevance. Combining an inexpensive smartphone-based readout and fabricated with low-cost carbon and polylactic acid (PLA) filaments, this device offers a scalable and field-deployable approach to real-time, decentralized diagnostics. The proposed prototype fills a critical void between laboratory analysis and standard healthcare needs and promotes accessible and affordable metabolic monitoring for underserved populations.

18 March 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
SPSangeeta Dnyaneshwar Palekar
Sangeeta Dnyaneshwar Palekar
SKSharayu Kalambe
Sharayu Kalambe
JKJayu Kalambe
Jayu Kalambe
Madhusudan KulkarniMadhusudan Kulkarni
Madhusudan Kulkarni
Manish BhaiyyaManish Bhaiyya
Manish Bhaiyya
Detecting kidney function biomarkers is critical for the early diagnosis of kidney diseases and monitoring treatment efficacy. In this work, a portable, 3D-printed colorimetric sensor platform was developed to detect key kidney biomarkers: uric acid, creatinine, and albumin. The platform features a 3D-printed enclosure with integrated diffused LED lighting to ensure a controlled environment for image acquisition. A disposable 3D-printed flow cell holds samples, ensuring precision and minimizing contamination. The sensor relies on colorimetric analysis, where a reagent reacts with blood serum to produce a color shift proportional to the biomarker concentration. Using a smartphone, the color change is captured, and RGB values are normalized to calculate concentrations based on the Beer-Lambert Law. The system adapts to variations in smartphones, reagent brands, and lighting conditions through an adaptive calibration algorithm, ensuring flexibility and accuracy. The sensor demonstrated good linear detection ranges for uric acid (1–30 mg/dL), creatinine (0.1–20 mg/dL), and albumin (0.1–8 g/dL), with detection limits of 1.15 mg/dL, 0.15 mg/dL, and 0.11 g/dL, respectively. These results correlated well with commercial biochemistry analyzers. Additionally, an Android application was developed to handle image processing and database management, providing a user-friendly interface for real-time blood analysis. This portable, cost-effective platform shows significant potential for point-of-care diagnostics and remote health monitoring.